Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/44643
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships |
Autor: | Campillo, Nuria E. CSIC ORCID ; Goya, Pilar CSIC ORCID; Páez, Juan A. CSIC ORCID | Fecha de publicación: | 26-ago-1999 | Editor: | American Chemical Society | Citación: | Journal of Medicinal Chemistry 42 (17) : 3279–3288 (1999) | Resumen: | In the previous paper (Part 1), we described the synthesis and antiplatelet activity of a series of phenyl- and heteroarylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides. In this paper, we report the optimization of the platelet aggregation inhibitory activity by an iterative sequence of quantitative structure-activity relationship studies which encompassed synthesis and evaluation of the effects of structure variations at the 1-, 6-, and 7-positions of the heterocyclic system. A model has been established that correctly correlates antiplatelet activity in this series with the partial atomic charges calculated by a local density functional ab initio method. As a result of this study, the experimental platelet aggregation inhibitory activity of the lead compound was improved 300-fold | Versión del editor: | http://dx.doi.org/10.1021/jm981104b | URI: | http://hdl.handle.net/10261/44643 | DOI: | 10.1021/jm981104b | ISSN: | 0022-2623 |
Aparece en las colecciones: | (IQM) Artículos |
Mostrar el registro completo
CORE Recommender
SCOPUSTM
Citations
13
checked on 28-mar-2024
WEB OF SCIENCETM
Citations
6
checked on 28-feb-2024
Page view(s)
316
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.